PCOS and Heart Health: Understanding the Role of Insulin and Metabolism

Polycystic Ovary Syndrome (PCOS) is one of the most common hormonal conditions affecting women of reproductive age. Beyond its well-known effects on menstrual cycles, fertility, and hormone balance, growing scientific evidence highlights a strong connection between PCOS, insulin resistance, and long-term heart health. Understanding this link is essential for early prevention and lifelong metabolic wellness.

PCOS, Insulin Resistance, and Metabolic Imbalance

Insulin resistance is considered a core feature of PCOS and affects up to 75% of women with the condition. When the body becomes less responsive to insulin, higher insulin levels are required to maintain normal blood glucose. This state of hyperinsulinemia does more than disrupt blood sugar—it directly influences hormone production.

Elevated insulin stimulates ovarian these cells to produce more androgens (such as testosterone) while reducing aromatase activity, the enzyme that converts testosterone into estrogen. This hormonal imbalance contributes to irregular periods, acne, excess hair growth, and impaired ovulation. At the same time, insulin resistance promotes weight gain, particularly around the abdomen, further worsening metabolic dysfunction.

Why Insulin Resistance Matters for Heart Health

Insulin resistance does not exist in isolation. It affects multiple organs, including fat tissue, muscles, the liver, and the cardiovascular system. Women with PCOS often develop additional cardiometabolic risk factors such as:

• Elevated body mass index (BMI)
  
• Dyslipidemia (abnormal cholesterol levels)
  
• Hypertension
  
• Impaired glucose tolerance or type 2 diabetes (T2D)

 

Large cohort studies have shown that women with PCOS who also develop diabetes experience significantly higher rates of heart failure, arrhythmias, cerebrovascular disease, kidney disease, and all-cause mortality compared to women with PCOS alone. These risks often appear earlier in life, emphasizing the importance of early screening and metabolic support.

PCOS is increasingly recognized as a chronic low-grade inflammatory condition. Women with PCOS often show elevated inflammatory markers such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). Chronic inflammation accelerates atherosclerosis, damages blood vessels, and further increases cardiovascular risk.

When inflammation, insulin resistance, and hormonal imbalance coexist—as they frequently do in PCOS—the cumulative effect can place significant strain on the heart and metabolic system over time.

Early Detection and the Role of Modern Tools

One challenge in PCOS management is diagnostic variability. Differences in diagnostic criteria across medical societies can delay diagnosis, especially in adolescents. Emerging research highlights the potential of advanced, explainable machine-learning models that use established clinical markers such as BMI, anti-Müllerian hormone (AMH), and menstrual regularity to support early risk identification.

These tools aim to complement—not replace—clinical judgment by improving transparency and helping healthcare professionals personalize care strategies, particularly for women at higher metabolic or cardiovascular risk.

Supporting Metabolic and Heart Health in PCOS

At Elan Healthcare, women’s wellness is viewed through a long-term, whole-body lens. Supporting insulin balance, hormonal health, and metabolic wellness early may help reduce future cardiovascular risk. Evidence-based lifestyle approaches commonly emphasized in PCOS management include:

• Balanced nutrition that supports blood sugar stability
• Regular physical activity tailored to metabolic health
  
• Stress management and sleep support
  
• Early screening for insulin resistance and diabetes
  
  

Addressing PCOS is not only about symptom relief—it is about protecting long-term heart health and overall wellbeing.

Supporting PCOS with Science-Backed Nutrients

Research shows that Myo-Inositol and D-Chiro-Inositol, especially in a natural 40:1 ratio, can help support insulin sensitivity, hormonal balance, and menstrual regularity in PCOS. Based on this evidence, Elan Healthcare’s Ovofolic is formulated to support metabolic and reproductive wellness as part of a balanced lifestyle.

Conclusion

PCOS and heart health are deeply connected through insulin resistance, metabolic dysfunction, and chronic inflammation. Recognizing these links empowers women and healthcare providers to act early. With timely screening, informed lifestyle choices, and supportive care, women with PCOS can take meaningful steps toward lifelong metabolic and cardiovascular health.

References

1. Impact of Diabetes on Cardiovascular Outcomes in PCOS Patients. American Heart Journal.
   
    https://pmc.ncbi.nlm.nih.gov/articles/PMC12520869/
   
   
2. Cardiometabolic Risk in PCOS. Frontiers in Endocrinology.
   
    https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1669716/full
   
   
3. Cardiovascular Risk Factors in PCOS. PMC.
   
    https://pmc.ncbi.nlm.nih.gov/articles/PMC12436438/
   
   
4. Insulin Resistance and PCOS Mechanisms. Scientific Reports.
   
    https://www.nature.com/articles/s41598-025-26718-2
   
   
5. Cardiovascular Risks in Women with PCOS: A Narrative Review.
   
    https://auctoresonline.com/article/cardiovascular-risks-in-women-with-polycystic-ovary-syndrome-pcos-a-narrative-review